Seeking Alpha

More on Qiagen (QGEN): Q2 earnings were nearly flat as the provider of medical-testing...

More on Qiagen (QGEN): Q2 earnings were nearly flat as the provider of medical-testing technologies revenue growth was masked by higher acquisition-related costs and other expenses. The company raises its FY12 EPS estimate to $1.04 - $1.06 on sales growth of 8% - 9%, versus its prior estimate of $1.03 - $1.05 on sales growth of 6% - 8%, and unveils a stock buyback of up to $100M.

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs